163 related articles for article (PubMed ID: 27376897)
21. The relationship between fibroblast growth factor 23 and osteoporosis in postmenopausal women.
Celik E; Guzel S; Abali R; Guzelant AY; Celik Guzel E; Kuçukyalcin V
Minerva Med; 2013 Oct; 104(5):497-504. PubMed ID: 24101107
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].
Krupa B
Ann Acad Med Stetin; 2000; 46():165-76. PubMed ID: 11712302
[TBL] [Abstract][Full Text] [Related]
23. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
[TBL] [Abstract][Full Text] [Related]
24. Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis.
Penido MG; Lima EM; Marino VS; Tupinambá AL; França A; Souto MF
Pediatr Nephrol; 2003 Feb; 18(2):133-9. PubMed ID: 12579402
[TBL] [Abstract][Full Text] [Related]
25. Urinary alpha and beta C-telopeptides of collagen I: clinical implications in bone remodeling in patients with anorexia nervosa.
de la Piedra C; Calero JA; Traba ML; Asensio MD; Argente J; Muñoz MT
Osteoporos Int; 1999; 10(6):480-6. PubMed ID: 10663349
[TBL] [Abstract][Full Text] [Related]
26. Association between markers of bone loss and urinary lithogenic risk factors in osteopenic postmenopausal women.
Granchi D; Caudarella R; Ripamonti C; Spinnato P; Bazzocchi A; Torreggiani E; Massa A; Baldini N
J Biol Regul Homeost Agents; 2016; 30(4 Suppl 1):145-151. PubMed ID: 28002912
[TBL] [Abstract][Full Text] [Related]
27. Assessment of bone mineral density and bone metabolism in young male adults recently diagnosed with systemic lupus erythematosus in China.
Guo Q; Fan P; Luo J; Wu S; Sun H; He L; Zhou B
Lupus; 2017 Mar; 26(3):289-293. PubMed ID: 27522093
[TBL] [Abstract][Full Text] [Related]
28. Nephrolithiasis during the first 6 months of life in exclusively breastfed infants.
Yılmaz N; Yüksel S; Altıntaş F; Koçyiğit A
Pediatr Nephrol; 2021 May; 36(5):1227-1231. PubMed ID: 33150500
[TBL] [Abstract][Full Text] [Related]
29. Metabolic investigation in patients with nephrolithiasis.
Santos FMD; Peres AK; Mandotti MR; Peres LAB
Einstein (Sao Paulo); 2017; 15(4):452-456. PubMed ID: 29267427
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of bone mineral density of the lumbar spine in patients with beta-thalassemia major with dual-energy x-ray absorptiometry and quantitative computed tomography: a comparison study.
Angelopoulos NG; Katounda E; Rombopoulos G; Goula A; Kaltzidou V; Kaltsas D; Ioannis P; Tolis G
J Pediatr Hematol Oncol; 2006 Feb; 28(2):73-8. PubMed ID: 16462577
[TBL] [Abstract][Full Text] [Related]
31. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis.
Lumachi F; Ermani M; Camozzi V; Tombolan V; Luisetto G
Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E60-3. PubMed ID: 19751416
[TBL] [Abstract][Full Text] [Related]
32. Bone mineral status, bone turnover markers and vitamin D status in children with congenital adrenal hyperplasia.
Okten A; Cakir M; Makuloglu M
Minerva Endocrinol; 2012 Sep; 37(3):275-82. PubMed ID: 22766894
[TBL] [Abstract][Full Text] [Related]
33. Effect of walking exercise on bone metabolism in postmenopausal women with osteopenia/osteoporosis.
Yamazaki S; Ichimura S; Iwamoto J; Takeda T; Toyama Y
J Bone Miner Metab; 2004; 22(5):500-8. PubMed ID: 15316873
[TBL] [Abstract][Full Text] [Related]
34. [Association between bone turnover markers, bone mineral density and vitamin D in Moroccan postmenopausal women].
Elmaataoui A; Elmachtani Idrissi S; Dami A; Bouhsain S; Chabraoui L; Ouzzif Z
Pathol Biol (Paris); 2014 Feb; 62(1):49-54. PubMed ID: 24461391
[TBL] [Abstract][Full Text] [Related]
35. Bone metabolism and vitamin D status in patients with multiple sclerosis.
Kępczyńska K; Zajda M; Lewandowski Z; Przedlacki J; Zakrzewska-Pniewska B
Neurol Neurochir Pol; 2016; 50(4):251-7. PubMed ID: 27375138
[TBL] [Abstract][Full Text] [Related]
36. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
Brzóska MM; Moniuszko-Jakoniuk J
Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
[TBL] [Abstract][Full Text] [Related]
37. Bone mineral density and bone turnover in patients with psoriatic arthritis.
Borman P; Babaoğlu S; Gur G; Bingol S; Bodur H
Clin Rheumatol; 2008 Apr; 27(4):443-7. PubMed ID: 17876648
[TBL] [Abstract][Full Text] [Related]
38. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of immunoreactive bone sialoprotein in osteoporosis: positive relations to established biochemical parameters of bone turnover.
Fassbender WJ; Ruf T; Kaiser HE; Stracke H
In Vivo; 2000; 14(5):619-24. PubMed ID: 11125546
[TBL] [Abstract][Full Text] [Related]
40. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.
Black DM; Greenspan SL; Ensrud KE; Palermo L; McGowan JA; Lang TF; Garnero P; Bouxsein ML; Bilezikian JP; Rosen CJ;
N Engl J Med; 2003 Sep; 349(13):1207-15. PubMed ID: 14500804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
